Clinically actionable genomic alterations in breast cancer brain metastases
Authors:
- G. GriguoloGGG. Griguolo
- A. ColleseiACA. Collesei
- E. LazzariniELE. Lazzarini
- M. BottossoMBM. Bottosso
- M.V. DieciMDM.V. Dieci
- S. FinebergSFS. Fineberg
- L. BauchetLBL. Bauchet
- G. LandaGLG. Landa
- F. MigliettaFMF. Miglietta
- J. JacobJJJ. Jacob
- V. RigauVRV. Rigau
- M. La CommareMCM. La Commare
Open Access
Abstract
No abstract availableFunding Information
- Fondazione AIRC per la ricerca sul cancro ETS
- Università degli Studi di Padova
- Ministero della Salute
This publication has 40 references indexed in Scilit:
- Metastatic breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†Annals of Oncology, 2026
- Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectivesCritical Reviews in Oncology/Hematology, 2024
- Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working GroupAnnals of Oncology, 2024
- Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancerESMO Open, 2024
- Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working GroupAnnals of Oncology, 2020
- Patterns of recurrence and metastasis in BRCA1/BRCA2‐associated breast cancersCancer, 2019
- Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancerJournal of Neuro-Oncology, 2018
- Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancerEuropean Journal of Cancer, 2017
- Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain MetastasesJAMA Oncology, 2017
- Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain MetastasesThe American Journal of Pathology, 2013